InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: staccani post# 1567

Saturday, 10/28/2017 5:40:38 PM

Saturday, October 28, 2017 5:40:38 PM

Post# of 2099
You're comparing apples to oranges. Tocagen's data is from recurrent HGG. VBL is recurrent GBM (grade 4).

I haven't seen the details of the CRs for Tocagen but yes, the reported results look very good. It looks like the FDA has seen something that it liked -- very much.

I would compare VBL against other rGBM treatments only.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News